PCN96 - Cost-Effectiveness Analysis of Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in the United States.

Subjects

Subjects :

*THYROID cancer treatment
*PHENYLUREA compounds
*IODINE isotopes
*PROTEIN-tyrosine kinase inhibitors
*SORAFENIB
*COST effectiveness

Details

Language :

English

ISSN :

10983015

Volume :

19

Issue :

3

Database :

Academic Search Index

Journal :

Value in Health

Publication Type :

Academic Journal

Accession number :

115550621

Full Text :

https://doi.org/10.1016/j.jval.2016.03.1595